x-risk frontierBio & pandemic risk AI & x-riskhumans affected:high· updated 2026-06-09

Biosecurity & pandemic preparedness

Prevent engineered and naturally-emerging pandemics from wiping out humanity or crippling civilization.

The scale of it

20Mworsening

excess deaths in the last major pandemic (COVID-19)

source: WHO estimated ~14.8M excess deaths in 2020-21; later totals ~20M. Engineered-pandemic risk is rising as DNA synthesis and gain-of-function capability spread.

The capital on it

$4B/yr↘ fallingunderallocated · 0.006× fair share

Dedicated pandemic-preparedness R&D and philanthropy (BARDA, CEPI, Open Phil biosecurity). Excludes routine public-health systems. Post-COVID supplemental funding has wound down — preparedness is being defunded while risk grows.

2021 – 2025

source: US ASPR/BARDA budgets + Open Philanthropy biosecurity grants (estimate) · confidence low · estimate, improvable by PR

The prize at the limit

$200Bin-the-limit market cap, if the team executes perfectly

The company that becomes the world’s standing pandemic-defense layer — detection, rapid countermeasures, secure supply — sells to every government, with defense-budget durability and biotech upside.

comparable: a defense prime crossed with Moderna · confidence low · a ceiling, not a forecast

The trade: demand is high, only $4B/yr of capital is flowing (0.006× its fair share), and the prize at the limit is $200B. This is a Request for Startups and a Request for Investors at once.

Whitepaper · v0.1 · open to refutation→

The summary lives here. The full whitepaper walks through the four-axis ranking, existing alternatives, proposed direction, cost & scale, and suggested investors — in the spirit of Hyperloop Alpha.

Quantity · humans affected

8.1Bhumans

source: 80,000 Hours biosecurity profile

Severity · WTP / wealth

85%low

share of affected person’s wealth they would pay for a solution

Current solutions

3.0/ 10med

quality of existing solutions — low score = high opportunity

Market size · TAM

$100.0Blow

USD / year the world is already paying

Time · OOM to impact

12ylow

order-of-magnitude horizon to civilizational-scale impact

Capital · OOM to solve

$500.0Blow

cumulative R&D + deployment + supply chain across the arc

Priority score

importance × urgency, 0–100

Importance

humans affected × severity, gated by market

Urgency

direction of travel + solution gap

Neglectedness

4/10

Funding rose after COVID-19, but pathogen-agnostic early warning and rapid global manufacturing remain underbuilt relative to the tail risk.

med

Tractability

6/10

Concrete tools exist or are near: metagenomic surveillance, far-UVC sterilization, and rapid platform vaccines. The gating problems are deployment and policy, not science.

med

Ways to help

Career

Work in biosecurity research or policy; 80,000 Hours rates it a top problem. →

Build

Build pathogen-agnostic detection, far-UVC hardware, or rapid biomanufacturing.

Policy

Push mandatory DNA-synthesis screening and lab-safety standards.

Organizations

Johns Hopkins Center for Health Securityresearch
CEPIvaccine coalition
Nuclear Threat Initiative (bio)policy

People to follow

Kevin Esveltbiosecurity, MIT Media Lab
Tom Inglesbydirector, JHU Center for Health Security

Three-lens scoring

welfare · copenhagen BCRn/a

x-risk · 80k hours ITN

9.0 / 10high

utility delta · state-of-art vs physics

80%low

COVID-19 demonstrated the tail risk from a single pathogen. Dual-use gene synthesis, lab leaks, and deliberate misuse mean that worst-case pandemics could be civilization-ending. Tractable: far-UVC sterilization, early-warning surveillance, broad-spectrum countermeasures, pathogen-agnostic detection.

The success vision · 10 years horizon

If we solve this, here is the world we get.

med

Before · today

World detects novel pathogens months after they spread; vaccines take 12+ months to develop and longer to globally distribute.

After · 10 years

Pathogens detected within days via genomic surveillance; vaccines designed and manufactured in weeks; equitable global distribution. No mass-casualty pandemic events possible.